Improving Cell Recycling System to Treat Lysosomal Storage Disease

News   Jul 18, 2017 | Original Story from the NIH NCATS

 
Cell Recycling System Offers Therapeutic Entry Point for Rare Disease Treatment

The compound methyl-β-cyclodextrin turns on an enzyme, AMPK, triggering a response against a rare genetic disease, NPC1. Credit: NCATS

 
 
 

RELATED ARTICLES

Researchers Uncover Muscle Growth Inhibitor Activation Mechanism Aiding ALS Treatment Efforts

News

Researchers at the University of Cincinnati (UC) College of Medicine are part of an international team that has identified how the inactive or latent form of GDF8, a signaling protein also known as myostatin responsible for limiting muscle, is activated.

READ MORE

Cancer Stem Cell Survival is Controlled by Hedgehog Signaling Proteins

News

Research reveals that cancer stem cell survival is controlled by a specific feature of the Hedgehog signaling pathway (SHH-PTCH1), which allows cells to respond to external signals in addition to inhibiting stem cell differentiation.

READ MORE

Synthetic Horsepox Virus Could Lead to More Effective Smallpox Vaccine

News

University of Alberta researchers created a new synthetic virus that could lead to the development of a more effective vaccine against smallpox.

READ MORE

 

Comments | 0 ADD COMMENT

Like what you just read? You can find similar content on the communities below.

Biopharma Cell Science Neuroscience Immunology & Microbiology

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE